Axon Enterprise (NASDAQ:AXON) Given Outperform Rating at William Blair

Axon Enterprise (NASDAQ:AXON)‘s stock had its “outperform” rating reissued by equities researchers at William Blair in a note issued to investors on Wednesday, RTT News reports.

A number of other research firms have also recently commented on AXON. Barclays upped their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an “overweight” rating in a research report on Thursday, February 29th. Argus began coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 target price on the stock. JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, April 11th. StockNews.com cut shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th. Finally, The Goldman Sachs Group upped their target price on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $312.64.

Axon Enterprise Trading Up 0.3 %

Shares of AXON stock traded up $0.98 on Wednesday, hitting $302.54. 183,713 shares of the stock traded hands, compared to its average volume of 467,233. The firm’s 50-day moving average price is $302.15 and its two-hundred day moving average price is $260.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00. The stock has a market capitalization of $22.83 billion, a PE ratio of 131.54 and a beta of 0.93. Axon Enterprise has a twelve month low of $175.37 and a twelve month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analysts’ expectations of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. As a group, analysts anticipate that Axon Enterprise will post 2.44 EPS for the current year.

Institutional Trading of Axon Enterprise

Large investors have recently made changes to their positions in the company. ICA Group Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth approximately $26,000. Trivant Custom Portfolio Group LLC acquired a new position in Axon Enterprise in the first quarter valued at approximately $31,000. First PREMIER Bank acquired a new position in Axon Enterprise in the first quarter valued at approximately $33,000. BKM Wealth Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at approximately $32,000. Finally, Rise Advisors LLC boosted its holdings in Axon Enterprise by 49.0% in the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock valued at $45,000 after purchasing an additional 47 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.